FFA
RMD icon

Founders Financial Alliance’s ResMed RMD Stock Holding History

Founders Financial Alliance’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,360
Closed -$305K – 814
2026
Q1 		$305K Sell
1,360
-31
-2% -$7.72K 0.06% 294
2025
Q4 		$335K Sell
1,391
-11
-0.8% -$2.81K 0.06% 258
2025
Q3 		$384K Buy
1,402
+18
+1% +$4.92K 0.07% 247
2025
Q2 		$357K Sell
1,384
-88
-6% -$21K 0.08% 228
2025
Q1 		$330K Buy
+1,472
New +$344K 0.08% 234
2020
Q4 		– Sell
-3
Closed -$1K – 1071
2020
Q3 		$1K Buy
+3
New +$554 ﹤0.01% 1313

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Founders Financial Alliance's RMD Position: Q2 2026 in Review

Founders Financial Alliance sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,360 shares — an estimated $305K sold.

Founders Financial Alliance first reported a position in RMD in Q3 2020 and held it in 6 quarters. The position peaked at $384K in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Founders Financial Alliance reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Founders Financial Alliance sold 1,360 ResMed shares in Q2 2026, an estimated $305K.
  • Founders Financial Alliance first reported a position in ResMed in Q3 2020 and held it in 6 quarters.
  • Founders Financial Alliance's ResMed position peaked at $384K in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Founders Financial Alliance's 13F filing for Q2 2026, filed 4 Aug 2026.